Compare Pfizer with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs CADILA HEALTHCARE - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER CADILA HEALTHCARE PFIZER/
CADILA HEALTHCARE
 
P/E (TTM) x 48.3 34.7 139.1% View Chart
P/BV x 8.0 6.1 131.7% View Chart
Dividend Yield % 0.4 0.6 75.1%  

Financials

 PFIZER   CADILA HEALTHCARE
EQUITY SHARE DATA
    PFIZER
Mar-19
CADILA HEALTHCARE
Mar-20
PFIZER/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs3,840352 1,090.0%   
Low Rs2,080207 1,007.3%   
Sales per share (Unadj.) Rs455.0139.2 326.8%  
Earnings per share (Unadj.) Rs93.811.8 797.1%  
Cash flow per share (Unadj.) Rs109.418.6 589.1%  
Dividends per share (Unadj.) Rs22.503.50 642.9%  
Dividend yield (eoy) %0.81.3 60.7%  
Book value per share (Unadj.) Rs658.2101.4 649.4%  
Shares outstanding (eoy) m45.751,023.74 4.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x6.52.0 324.2%   
Avg P/E ratio x31.623.7 132.9%  
P/CF ratio (eoy) x27.115.0 179.8%  
Price / Book Value ratio x4.52.8 163.1%  
Dividend payout %24.029.8 80.6%   
Avg Mkt Cap Rs m135,420286,033 47.3%   
No. of employees `0002.613.4 19.6%   
Total wages/salary Rs m3,23824,145 13.4%   
Avg. sales/employee Rs Th7,911.410,632.7 74.4%   
Avg. wages/employee Rs Th1,230.91,801.2 68.3%   
Avg. net profit/employee Rs Th1,630.7898.5 181.5%   
INCOME DATA
Net Sales Rs m20,815142,531 14.6%  
Other income Rs m1,6741,139 147.0%   
Total revenues Rs m22,489143,670 15.7%   
Gross profit Rs m5,71224,198 23.6%  
Depreciation Rs m7146,965 10.2%   
Interest Rs m733,418 2.1%   
Profit before tax Rs m6,59914,954 44.1%   
Minority Interest Rs m0288 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,3093,198 72.2%   
Profit after tax Rs m4,29112,044 35.6%  
Gross profit margin %27.417.0 161.6%  
Effective tax rate %35.021.4 163.6%   
Net profit margin %20.68.5 243.9%  
BALANCE SHEET DATA
Current assets Rs m27,16787,154 31.2%   
Current liabilities Rs m8,91782,694 10.8%   
Net working cap to sales %87.73.1 2,801.9%  
Current ratio x3.01.1 289.1%  
Inventory Days Days6871 94.9%  
Debtors Days Days3094 32.1%  
Net fixed assets Rs m8,862133,236 6.7%   
Share capital Rs m4581,024 44.7%   
"Free" reserves Rs m29,656102,733 28.9%   
Net worth Rs m30,113103,757 29.0%   
Long term debt Rs m2532,146 0.1%   
Total assets Rs m39,400236,866 16.6%  
Interest coverage x91.55.4 1,702.7%   
Debt to equity ratio x00.3 0.3%  
Sales to assets ratio x0.50.6 87.8%   
Return on assets %11.16.5 169.7%  
Return on equity %14.211.6 122.7%  
Return on capital %22.113.7 161.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m42852,752 0.8%   
Fx outflow Rs m78614,504 5.4%   
Net fx Rs m-35838,248 -0.9%   
CASH FLOW
From Operations Rs m97825,054 3.9%  
From Investments Rs m351-10,123 -3.5%  
From Financial Activity Rs m-1,099-10,942 10.0%  
Net Cashflow Rs m2313,989 5.8%  

Share Holding

Indian Promoters % 0.0 74.8 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 8.3 90.4%  
FIIs % 4.9 5.9 83.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 11.0 215.5%  
Shareholders   85,207 44,069 193.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   STRIDES PHARMA SCIENCE  AJANTA PHARMA  SUVEN LIFE SCIENCES  ALEMBIC PHARMA  WOCKHARDT  

Compare PFIZER With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty End Flat; Asian Paints, UPL & ITC Among Top Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 40.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 40.6% YoY). Sales on the other hand came in at Rs 38 bn (up 4.3% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

PFIZER Announces Quarterly Results (1QFY21); Net Profit Up 10.3% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, PFIZER has posted a net profit of Rs 1 bn (up 10.3% YoY). Sales on the other hand came in at Rs 5 bn (down 5.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

Is Intraday Trading For You?(Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution(Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


May 14, 2021 (Close)

TRACK PFIZER

PFIZER - WYETH COMPARISON

COMPARE PFIZER WITH

MARKET STATS